Universal Health Services (NYSE:UHS) Price Target Cut to $230.00 by Analysts at Mizuho

Universal Health Services (NYSE:UHS) had its price target trimmed by Mizuho from $267.00 to $230.00 in a report published on Wednesday morning,MarketScreener reports. The firm currently has an outperform rating on the health services provider’s stock.

Several other equities analysts have also commented on UHS. Deutsche Bank Aktiengesellschaft decreased their target price on shares of Universal Health Services from $261.00 to $230.00 and set a “buy” rating on the stock in a report on Wednesday. Wells Fargo & Company cut their target price on shares of Universal Health Services from $235.00 to $212.00 and set an “equal weight” rating on the stock in a research report on Monday, March 2nd. TD Cowen cut their target price on shares of Universal Health Services from $245.00 to $230.00 and set a “buy” rating on the stock in a research report on Wednesday. Robert W. Baird dropped their price target on shares of Universal Health Services from $241.00 to $204.00 and set a “neutral” rating on the stock in a research report on Wednesday. Finally, Guggenheim cut their price target on Universal Health Services from $238.00 to $211.00 and set a “buy” rating on the stock in a report on Wednesday. Six research analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $220.94.

Universal Health Services Stock Performance

Shares of UHS traded up $0.04 during trading hours on Wednesday, hitting $168.01. The company had a trading volume of 341,699 shares, compared to its average volume of 755,561. Universal Health Services has a 12 month low of $152.33 and a 12 month high of $246.32. The firm has a market cap of $10.26 billion, a price-to-earnings ratio of 7.00, a PEG ratio of 0.82 and a beta of 1.29. The business has a fifty day moving average of $190.23 and a 200-day moving average of $209.21. The company has a quick ratio of 0.98, a current ratio of 1.05 and a debt-to-equity ratio of 0.55.

Universal Health Services (NYSE:UHS) last released its quarterly earnings results on Monday, April 27th. The health services provider reported $5.62 EPS for the quarter, topping analysts’ consensus estimates of $5.36 by $0.26. Universal Health Services had a net margin of 8.56% and a return on equity of 19.78%. The business had revenue of $4.50 billion for the quarter, compared to analyst estimates of $4.39 billion. During the same period last year, the firm earned $4.84 earnings per share. Universal Health Services’s revenue for the quarter was up 9.6% compared to the same quarter last year. Universal Health Services has set its FY 2026 guidance at 22.640-24.520 EPS. Equities analysts anticipate that Universal Health Services will post 23.4 EPS for the current fiscal year.

Universal Health Services Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, March 16th. Investors of record on Monday, March 2nd were given a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date was Monday, March 2nd. Universal Health Services’s payout ratio is presently 3.33%.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of the stock. Pzena Investment Management LLC grew its stake in shares of Universal Health Services by 31.5% in the 4th quarter. Pzena Investment Management LLC now owns 2,112,604 shares of the health services provider’s stock worth $460,590,000 after acquiring an additional 505,575 shares in the last quarter. Dimensional Fund Advisors LP grew its stake in shares of Universal Health Services by 6.3% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,588,911 shares of the health services provider’s stock worth $346,447,000 after acquiring an additional 94,447 shares in the last quarter. Arrowstreet Capital Limited Partnership grew its stake in shares of Universal Health Services by 7.1% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 1,206,000 shares of the health services provider’s stock worth $262,932,000 after acquiring an additional 80,236 shares in the last quarter. Norges Bank bought a new stake in shares of Universal Health Services in the 4th quarter worth $199,334,000. Finally, Morgan Stanley grew its stake in shares of Universal Health Services by 59.5% in the 4th quarter. Morgan Stanley now owns 871,377 shares of the health services provider’s stock worth $189,978,000 after acquiring an additional 325,162 shares in the last quarter. Institutional investors and hedge funds own 86.05% of the company’s stock.

Trending Headlines about Universal Health Services

Here are the key news stories impacting Universal Health Services this week:

• Positive Sentiment: Q1 earnings beat — UHS reported stronger‑than‑expected Q1 results driven by behavioral‑health admissions and patient‑day growth, which lifted revenue and EPS above consensus. This supports the company’s near‑term fundamentals and underpins management’s guidance. Article Title
• Positive Sentiment: FY‑2026 guidance provided — Management set FY‑2026 EPS guidance at 22.640–24.520, implying continued profitability and backing analyst estimates that expect roughly ~23.4 EPS for the year; this gives a clear earnings framework for investors to model. Earnings Transcript
• Positive Sentiment: Some brokers remain constructive despite cuts — Mizuho, Deutsche Bank and TD Cowen trimmed targets but maintained Outperform/Buy ratings, leaving sizeable upside in their revised targets and signaling continued conviction in UHS’s recovery trajectory. Mizuho Deutsche Bank TD Cowen
• Neutral Sentiment: Long‑term value narrative — Analyst commentary (Zacks) highlights UHS as a value pick for long‑term investors based on earnings power and valuation metrics; useful for buy‑and‑hold accounts but less relevant for short‑term price moves. Zacks Article
• Negative Sentiment: Multiple price‑target cuts — Several firms (Stephens, Morgan Stanley, RBC, Robert W. Baird and others) lowered price targets and moved to Equal Weight/Neutral/Sector Perform stances, which increases downside pressure from analysts and may limit near‑term gains despite the earnings beat. Stephens Morgan Stanley RBC Baird
• Negative Sentiment: Technical and liquidity headwinds — UHS is trading below its 50‑ and 200‑day moving averages with lighter-than-average volume, which can amplify selling and make breakouts harder until momentum reverses (short‑term negative for price action).

About Universal Health Services

Universal Health Services, Inc (NYSE: UHS) is one of the largest diversified health care management companies in the United States, offering a broad spectrum of services through its acute care hospital and behavioral health segments. The company operates general acute care hospitals, surgical hospitals and ambulatory centers, as well as inpatient and outpatient behavioral health facilities. Its network provides emergency and specialized medicine, diagnostic imaging, laboratory services, advanced surgical care and rehabilitation, complemented by a comprehensive array of behavioral services including psychiatric treatment, addiction programs and developmental disabilities care.

In the acute care segment, UHS’s facilities deliver services ranging from emergency department treatment and intensive care to maternity care and outpatient surgery.